LIR Life Sciences Corp. (CSE:SKNY)

Canada flag Canada · Delayed Price · Currency is CAD
1.370
-0.010 (-0.72%)
At close: Feb 6, 2026
204.44%
Market Cap38.18M
Revenue (ttm)n/a
Net Income-566.64K
EPS-0.04
Shares Out27.87M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume48,039
Average Volume123,832
Open1.370
Previous Close1.380
Day's Range1.370 - 1.400
52-Week Range0.450 - 2.410
Betan/a
RSI32.25
Earnings DateMar 31, 2026

About LIR Life Sciences

LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada. [Read more]

Industry Pharmaceutical Preparations
Founded 2024
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol SKNY
Full Company Profile

Financial Performance

Financial Statements